CD4 and HIV-1 infection: Therefore, as for HCV infection, SIL may modulate fundamental metabolic processes that result in the blunting of multiple cellular responses including activation and proliferation, which ultimately renders CD4+ T cells less susceptible to HIV-1 infection.